Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02524379 · ClinicalTrials.gov registry record · Phase 1
Spinal Cord Injury Neuroprotection With Glyburide
A Phase 1 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02524379: Clinical Trial Phase 1 study, sponsored by Ohio State University.
NCT02524379 is a Phase 1 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02524379, a Phase 1 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of using oral Glyburide in patients with acute traumatic cervical spinal cord injuries (SCI).
Primary Outcome
A measure of feasibility of undertaking a larger phase II study among this population of patients where treatment must begin within a short injury-to-drug time window.
Interventions
- DRUG Glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2021-02-08 |
| Phase | Phase 1 |
Why NCT02524379 stopped before completion
NCT02524379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Glyburide is the first listed.
NCT02524379 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02524379 about?
NCT02524379 is a clinical study titled "Spinal Cord Injury Neuroprotection With Glyburide". The purpose of this study is to determine the safety of using oral Glyburide in patients with acute traumatic cervical spinal cord injuries (SCI).
What is the current status of trial NCT02524379?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2017-02-14. Estimated completion is 2021-02-08.
What interventions are being tested in trial NCT02524379?
The interventions under investigation include: Glyburide (DRUG).
Who is sponsoring clinical trial NCT02524379?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02524379's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI